According to FutureWise analysis the market for albumin in 2023 is US$ 5.83 billion, and is expected to reach US$ 9.74 billion by 2031 at a CAGR of 6.60%.
Albumin is the most common type of protein in blood plasma, which helps maintain blood levels in arteries and veins and facilitates the transportation of hormones, enzymes, and vitamins throughout the body. The liver is responsible for its production, and once synthesized, albumin is quickly carried to the bloodstream. Healthy kidneys stop most of the albumin from entering the urine through filtration, resulting in minimal to no detectable albumin in the urine. However, if the kidneys are damaged, albumin can "leak" through their filters and into the urine. Lower levels of albumin in the blood indicate serious liver and kidney issues. High levels, known as hyperalbuminemia, can indicate conditions such as dehydration and diarrhea. The standard range for normal albumin levels is between 3.4 to 5.4 (g/dL) or 34 to 54 grams per liter (g/L).
There are three different types of albumin: human serum albumin (HSA), recombinant albumin, and bovine serum albumin (BSA). Human albumin, also known as Albuminex, is a packed globular protein with a molecular weight of 66.5 kilodaltons (kDa). It is composed of a single chain of 585 amino acids organized in three repeated homolog domains (sites I, II, and III). Each domain comprises two separate sub-domains (A and B). It has the highest demand among other biopharmaceutical solutions. Human albumin has interesting enzymatic properties, including esterase activity, enolase activity, effects on eicosanoids, aryl acylamidase activity, stereospecificity, and binding and activation of drug conjugates.
FutureWise Market Research has published a report that provides an insightful albumin market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, albumin market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.